Boothbay Fund Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-185,996
| Closed | -$327K | – | 1831 |
|
|
2024
Q3 | $327K | Hold |
185,996
| – | – | 0.01% | 1000 |
|
|
2024
Q2 | $218K | Buy |
185,996
+44,783
| +32% | +$52.4K | 0.01% | 1112 |
|
|
2024
Q1 | $1.28M | Sell |
141,213
-20,459
| -13% | -$185K | 0.02% | 568 |
|
|
2023
Q4 | $1.76M | Sell |
161,672
-292,200
| -64% | -$3.18M | 0.04% | 445 |
|
|
2023
Q3 | $3.65M | Buy |
453,872
+40,661
| +10% | +$327K | 0.09% | 255 |
|
|
2023
Q2 | $4.49M | Buy |
413,211
+392,297
| +1,876% | +$4.26M | 0.1% | 202 |
|
|
2023
Q1 | $144K | Sell |
20,914
-3,013
| -13% | -$20.8K | ﹤0.01% | 1589 |
|
|
2022
Q4 | $95.2K | Buy |
+23,927
| New | +$95.2K | ﹤0.01% | 1557 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2407 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2269 |
|
|
2020
Q1 | – | Sell |
-2,500
| Closed | -$22K | – | 1023 |
|
|
2019
Q4 | $22K | Buy |
+2,500
| New | +$22K | ﹤0.01% | 718 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 856 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 845 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 827 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 857 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 862 |
|
|
2017
Q3 | – | Sell |
-7,866
| Closed | -$43K | – | 732 |
|
|
2017
Q2 | $43K | Hold |
7,866
| – | – | 0.01% | 553 |
|
|
2017
Q1 | $56K | Sell |
7,866
-11,800
| -60% | -$84K | 0.01% | 608 |
|
|
2016
Q4 | $79 | Buy |
19,666
+6,558
| +50% | +$26 | 0.02% | 627 |
|
|
2016
Q3 | $95K | Buy |
+13,108
| New | +$95K | 0.02% | 560 |
|
|
2016
Q1 | – | Sell |
-2,815
| Closed | -$86K | – | 534 |
|
|
2015
Q4 | $86K | Buy |
+2,815
| New | +$86K | 0.04% | 474 |
|